Home
Scholarly Works
Costs Impact Rivaroxaban Plus Aspirin versus...
Conference

Costs Impact Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Authors

Lamy A; Eikelboom J; Connolly S; Bosch J; Fox KA; Tong W; Yuan F; Yusuf S

Volume

136

Pagination

pp. E456-E457

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

December 12, 2017

Name of conference

Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium

Conference place

CA, Anaheim

Conference start date

November 11, 2017

Conference end date

November 15, 2017

Conference proceedings

CIRCULATION

Issue

24

ISSN

0009-7322

Contact the Experts team